S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in
NASDAQ:WVE

Wave Life Sciences Stock Forecast, Price & News

$9.21
+0.20 (+2.22 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.99
Now: $9.21
$9.55
50-Day Range
$6.99
MA: $8.13
$9.14
52-Week Range
$6.61
Now: $9.21
$39.98
Volume848,591 shs
Average Volume774,706 shs
Market Capitalization$449.25 million
P/E RatioN/A
Dividend YieldN/A
Beta0.35
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Read More
Wave Life Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.82 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:WVE
CUSIPN/A
Phone65-6236-3388
Employees301

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.98 million
Book Value$1.86 per share

Profitability

Net Income$-193,640,000.00
Net Margins-1,562.01%

Miscellaneous

Market Cap$449.25 million
Next Earnings Date3/1/2021 (Estimated)
OptionableOptionable
$9.21
+0.20 (+2.22 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

How has Wave Life Sciences' stock been impacted by Coronavirus (COVID-19)?

Wave Life Sciences' stock was trading at $8.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WVE stock has increased by 13.4% and is now trading at $9.21.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Wave Life Sciences?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Wave Life Sciences
.

What stocks does MarketBeat like better than Wave Life Sciences?

Wall Street analysts have given Wave Life Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Wave Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Wave Life Sciences' next earnings date?

Wave Life Sciences is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for Wave Life Sciences
.

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd. (NASDAQ:WVE) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.86) EPS for the quarter, missing the Zacks' consensus estimate of ($0.73) by $0.13. Wave Life Sciences had a negative return on equity of 401.32% and a negative net margin of 1,562.01%.
View Wave Life Sciences' earnings history
.

What price target have analysts set for WVE?

7 brokers have issued twelve-month price targets for Wave Life Sciences' shares. Their forecasts range from $10.00 to $27.00. On average, they expect Wave Life Sciences' stock price to reach $19.14 in the next year. This suggests a possible upside of 107.8% from the stock's current price.
View analysts' price targets for Wave Life Sciences
.

Who are some of Wave Life Sciences' key competitors?

What other stocks do shareholders of Wave Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wave Life Sciences investors own include Gilead Sciences (GILD), Exelixis (EXEL), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), VBI Vaccines (VBIV), Aduro Biotech (ADRO), Cidara Therapeutics (CDTX), CRISPR Therapeutics (CRSP) and ImmunoGen (IMGN).

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the following people:
  • Dr. Paul B. Bolno M.B.A., M.D., MBA, Pres, CEO & Director (Age 46, Pay $881.53k)
  • Dr. Chandra Vargeese, Chief Technology Officer (Age 59, Pay $564.52k)
  • Dr. Michael A. Panzara M.P.H., M.D., MPH, Chief Medical Officer and Head of Therapeutics Discovery & Devel. (Age 53, Pay $597k)
  • Mr. David G. Gaiero, Interim Chief Financial Officer (Age 42)
  • Mr. Kyle B. Moran, Sr. VP of Fin. & Operations (Age 49)
  • Kate Rausch, Head of Investor Relations
  • Ms. Linda Rockett J.D., Gen. Counsel
  • Dr. Christopher Francis Ph.D., Sr. VP of Corp. Devel. & Head of Emerging Areas (Age 42)
  • Mr. Jose Juves, Sr. VP of Corp. Affairs & Patient Advocacy
  • Dr. Kenneth Rhodes, Sr. VP of Therapeutics Discovery

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

Who are Wave Life Sciences' major shareholders?

Wave Life Sciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (5.13%), BlackRock Inc. (6.73%), Nantahala Capital Management LLC (4.88%), JPMorgan Chase & Co. (3.10%), Morgan Stanley (3.08%) and Sphera Funds Management LTD. (2.55%). Company insiders that own Wave Life Sciences stock include Chandra Vargeese, Gregory L Verdine, Michael A Panzara, Paul Bolno and Ra Capital Management, Llc.
View institutional ownership trends for Wave Life Sciences
.

Which major investors are selling Wave Life Sciences stock?

WVE stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Schonfeld Strategic Advisors LLC, Schonfeld Strategic Advisors LLC, AXA S.A., State Street Corp, Quantitative Systematic Strategies LLC, and Virtus ETF Advisers LLC. Company insiders that have sold Wave Life Sciences company stock in the last year include Chandra Vargeese, Michael A Panzara, and Paul Bolno.
View insider buying and selling activity for Wave Life Sciences
.

Which major investors are buying Wave Life Sciences stock?

WVE stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Sphera Funds Management LTD., Nantahala Capital Management LLC, Hound Partners LLC, Voloridge Investment Management LLC, JPMorgan Chase & Co., BlackRock Inc., and Squarepoint Ops LLC.
View insider buying and selling activity for Wave Life Sciences
.

How do I buy shares of Wave Life Sciences?

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of WVE stock can currently be purchased for approximately $9.21.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $449.25 million and generates $15.98 million in revenue each year. The company earns $-193,640,000.00 in net income (profit) each year or ($5.72) on an earnings per share basis. Wave Life Sciences employs 301 workers across the globe.

What is Wave Life Sciences' official website?

The official website for Wave Life Sciences is www.wavelifesciences.com.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.